From our combined team: Time in Range (TIR) may help to predict amputation and mortality risk #ActAgainstAmputation @USC @USC_Vascular @KeckSchool_USC

This from our combined Chongqing/Singapore/USC team. This adds additional data pointing to a relationship with glucose, morbidity and mortality in high risk diabetic foot patients. Aims: To evaluate the association of time in range (TIR) with amputation and all-cause mortality in hospitalized patients with diabetic foot ulcers (DFUs) MATERIALS AND METHODS: A retrospective analysis was performed […]

Read More From our combined team: Time in Range (TIR) may help to predict amputation and mortality risk #ActAgainstAmputation @USC @USC_Vascular @KeckSchool_USC

An explainable machine learning model for predicting in‐hospital amputation rate of patients with diabetic foot ulcer

Just published this past week by our collective Chongqing/Singapore/and local LA squad. Diabetic foot ulcer (DFU) is one of the most serious and alarming diabetic complications, which often leads to high amputation rates in diabetic patients. Machine learning is a part of the field of artificial intelligence, which can automatically learn models from data and […]

Read More An explainable machine learning model for predicting in‐hospital amputation rate of patients with diabetic foot ulcer

Pay For Performance Reduces Incident Ulceration, Amputation, Death in the Diabetic Foot: Nationwide Study

A key Taiwanese nationwide study suggests that focusing on quality can improve outcomes. See for yourself: A nationwide cohort investigation on pay-for-performance and major adverse limb events in patients with diabetes A nationwide cohort investigation on pay-for-performance and major adverse limb events in patients with diabetes Highlights The nationwide population-base investigation unlinked vascular benefit of […]

Read More Pay For Performance Reduces Incident Ulceration, Amputation, Death in the Diabetic Foot: Nationwide Study

More evidence for “renal foot” angiographic findings and outcomes

Superb work from our long-time SALSAmigo, Prof. Luigi Uccioli and his team led by Meloni and coworkers. This confirms previous work by our team that there is indeed foot level as well as a much higher rate of revascularization failure in “RDF” patients compared to their “DF” counterparts.

Read More More evidence for “renal foot” angiographic findings and outcomes

Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014

Our data showed a higher incidence of LEA, especially minor LEA, in patients with T1D and T2D compared with those without diabetes, with a greater risk among patients with T1D than patients with T2D. Accounting for known and measurable risk factors for LEA reduced the relative hazard by nearly 50%; … — Read on pubmed.ncbi.nlm.nih.gov/32090430/ […]

Read More Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014

Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems – PubMed

The present study confirms the high mortality rates described in patients with diabetes after non-traumatic LEA. It shows differences between minor and major LEA in terms of mortality rates and related risk factors. The study highlights the role of depression as specific risk factor for death in pat … — Read on pubmed.ncbi.nlm.nih.gov/32690575/ Mortality at […]

Read More Survival and factors predicting mortality after major and minor lower-extremity amputations among patients with diabetes: a population-based study using health information systems – PubMed

Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis @ALPSlimb #ActAgainstAmputation @USC_vascular @apma @keckmedusc @DiabetesRC

Lower extremity reamputation in people with diabetes: a systematic reviewand meta-analysis This from Liu and our group evaluating the best available evidence on reamputation. The bottom line: 1 year reamputation: 19%, 5 year reamputation 37.1%, 5 year contralateral reamputation: 20.5%. No trend for improvement or worsening over the past 2 decades. Lower extremity reamputation in […]

Read More Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis @ALPSlimb #ActAgainstAmputation @USC_vascular @apma @keckmedusc @DiabetesRC